New Parkinson's drug Produodopa to be available on NHS –

[{"selector":"#anim-99c0aca6-6ed1-4dc1-95d7-91826ae94605","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-08c25bb2-89fc-49ec-a383-1737dd82ef6a","keyframes":{"transform":["rotate(-360deg) translate3d(109.96978%, 0px, 0) rotate(360deg)","rotate(-360deg) translate3d(0px, 0px, 0) rotate(360deg)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] – Nearly 1,000 people with advanced Parkinson's disease in the UK will benefit from the new treatment Produodopa, provided by NHS England.

– Produodopa utilizes a portable kit with a pump to administer medication continuously into the bloodstream, offering a consistent effect compared to traditional pill-based treatments.

[{"selector":"#anim-fc3f4c86-6986-4b66-a7dd-a1ca8afcf3b6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f1b7cd78-40ef-4c57-9cb9-0cf6c5adffc0","keyframes":{"transform":["translate3d(107.37463%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

– The treatment combines two drugs, foslevodopa and foscarbidopa, to convert into dopamine, aiding in symptom management such as excessive movement or tremors.

[{"selector":"#anim-ae55617e-e7c5-4768-8cc0-ab106ce5950c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6d6f1a6e-bc28-4649-862a-8c1f1547a940","keyframes":{"transform":["rotate(-360deg) translate3d(106.59342%, 0px, 0) rotate(360deg)","rotate(-360deg) translate3d(0px, 0px, 0) rotate(360deg)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-8684e547-357b-4850-b7e1-eca17a0eb453","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-004b841a-acb5-46e7-a6db-76e99741e27f","keyframes":{"transform":["translate3d(114.55696%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Patients receive the infusion through a cannula under the skin, controlled by an automatic pump that releases medication 24 hours a day

[{"selector":"#anim-591d1400-5489-4c35-901c-d5028e74fd43","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5c65a5b4-db8f-48c4-a848-20b99c05ff84","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] NHS England's medical director for specialised services, James Palmer, highlights the significance of the drug's availability

[{"selector":"#anim-446fae4d-d451-4e37-8722-2cd0cdafb704","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ab59cc09-5a5c-487f-8558-46e2891cacdc","keyframes":{"transform":["translate3d(114.96816%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] – Many current Parkinson's patients rely on over 20 pills daily, facing inconsistent symptom control, which can worsen throughout the day and night.

[{"selector":"#anim-3bd14a81-7acb-4c08-9b9f-16c9e1858544","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-549ae4dc-9845-47ff-ad55-e0aebb6906c1","keyframes":{"transform":["translate3d(115.92356%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Patients involved in clinical trials express positive experiences with the new treatment, citing improved symptom management and quality of life

[{"selector":"#anim-789967f9-1b2c-44e3-b4ec-83e8a593572e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-407657dc-1fad-40ac-8d3b-08d98c8f67a7","keyframes":{"transform":["translate3d(115.60510%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Parkinson's UK acknowledges Produodopa as a potential "life-changing option" for some patients, emphasizing the importance of consulting healthcare professionals

New Parkinson's drug Produodopa to be available on NHS –

– Produodopa utilizes a portable kit with a pump to administer medication continuously into the bloodstream, offering a consistent effect compared to traditional pill-based treatments.

– The treatment combines two drugs, foslevodopa and foscarbidopa, to convert into dopamine, aiding in symptom management such as excessive movement or tremors.

Army-Navy Game 2022

You Should Know

Click on Below